Mital Patel Cohen, MD
Dermatology · Florham Park, NJNPI 1619119583
Payments from drug & device makers
Across 658 payments — averaging $1213.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$327K
- Johnson & Johnson$244K
- AbbVie$194K
- Janssen Scientific Affairs, LLC$33K
- Boston Scientific$150
- Pacira Pharmaceuticals Incorporated$124
- plus $149 from 3 others
What the payments were for
- Consulting fees$44,3386%
- Speaking & faculty fees$696,03487%
- Travel & lodging$46,0656%
- Food & beverage$11,6791%
- Education$5320%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 341 | $326,909 |
| Johnson & Johnson | 147 | $244,312 |
| AbbVie | 134 | $194,366 |
| Janssen Scientific Affairs, LLC | 29 | $32,636 |
| Boston Scientific | 1 | $150 |
| Pacira Pharmaceuticals Incorporated | 1 | $124 |
| Galderma Laboratories, L.p. | 1 | $82 |
| LEO Pharma Inc. | 3 | $38 |
| Eli Lilly | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$275,100
- TALTZ$236,632
- Humira$101,119
- Skyrizi$79,520
- EBGLYSS$74,283
- SIMPONI ARIA$7,093
- Rinvoq$2,700
- SPECTRA WAVEWRITER$150
- EXPAREL$124
How this compares
$798,647 in reported general payments places this provider in the 95th percentile of 394 dermatology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 13 | $270,621 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 12 | $102,602 |
| Dupixent PenDupilumab | 19 | $72,771 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 101 | $4,982 |
| Fluorouracil | 49 | $3,135 |
| Clobetasol Propionate | 70 | $2,182 |
| Ketoconazole | 129 | $2,045 |
| Metronidazole | 34 | $1,476 |
| Triamcinolone Acetonide | 108 | $835 |
| Clindamycin Phosphate | 34 | $830 |
| Tacrolimus | 11 | $796 |
| Desonide | 19 | $617 |
| Azelaic Acid | 11 | $557 |
| Ammonium Lactate | 29 | $543 |
| Tretinoin | 13 | $541 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Florham Park
- Brian MachlerFlorham Park$346K
- Shari SperlingFlorham Park$26K
- Jerry BagelEast Windsor$15.4M
- Jonathan DosikGlen Rock$8.4M
- Omar NoorSomerset$4.6M
- Linda Cappiello-LindsleyHoboken$2.3M
- Winston MoyDenville$1.8M
- Brian KeeganEast Windsor$1.7M
- Jeanine DownieMontclair$1.2M
- Adolfo Fernandez ObregonHoboken$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.